Antimicrobial susceptibility of shiga toxin-producing Escherichia coli isolated from organic dairy farms, conventional dairy farms, and county fairs in Minnesota

Foodborne Pathogens and Disease

Volumn 4, Issue 2, 2007, Pages 178-186

  Cho, Seongbeom ^a   Fossler, Charles P ^a   Diez Gonzalez, Francisco ^a   Wells, Scott J ^a   Hedberg, Craig W ^a   Kaneene, John B ^b   Ruegg, Pamela L ^c   Warnick, Lorin D ^d   Bender, Jeffrey B ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXI INJECT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFAZOLIN; CEFOXITIN; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; ENROFLOXACIN; GENTAMICIN; ORBIFLOXACIN; PENICILLIN DERIVATIVE; SHIGA TOXIN; SPECTINOMYCIN; SULFADIMETHOXINE; TETRACYCLINE; TICARCILLIN; TIMENTIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COW; DAIRY CATTLE; ESCHERICHIA COLI; ESCHERICHIA COLI O157; FOOD CHAIN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; ORGANIC FARMING; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; COLONY COUNT, MICROBIAL; CONSUMER PRODUCT SAFETY; DAIRY PRODUCTS; DAIRYING; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI O157; FOOD CONTAMINATION; HUMANS; MICROBIAL SENSITIVITY TESTS; MINNESOTA;

BOS; ESCHERICHIA COLI;

EID: 34447278583     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2006.0074     Document Type: Article

References (22)

1. Borczyk AA, Karmali MA, Lior H, Duncan LM. Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet 1987;1(8524):98.
2. Cho S, Diez-Gonzalez F, Fossler CP, et al. Prevalence of shiga toxin-encoding bacteria and shiga toxin-producing Escherichia coli isolates from dairy farms and county fairs. Vet Microbiol 2006a;118:289-298.
3. Cho S, Bender JB, Diez-Gonzalez F, et al. Prevalence and characterization of Escherichia coli O157 isolates from Minnesota dairy farms and county fairs. J Food Prot 2006b;69:252-259.
4. Farina C, Goglio A, Conedera G, Minelli F, Caprioli A. Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy. Eur J Clin Microbiol Infect Dis 1996;15:351-353.
5. Johnson K, Marano N, Howard R, et al. The antimicrobial resistance patterns of Escherichia coli O157:H7-NARMS, 1996-1999. In: 2nd International Conference on Emerging Infectious Diseases, Atlanta, GA, July 2000.
6. Khachatryan AR, Hancock DD, Besser TE, Call DR. Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves. Appl Environ Microbiol 2004;70:752-757.
7. Khan A, Das SC, Ramamurthy T, et al. Antibiotic resistance, virulence gene, and molecular profiles of Shiga toxin-producing Escherichia coli isolates from diverse sources in Calcutta, India. J Clin Microbiol 2002;40:2009-2015.
8. Meng J, Zhao S, Doyle MP, Joseph SW, Antibiotic resistance of Escherichia coli O157:H7 and O157:NM isolated from animals, food, and humans. J Food Prot 1998;61:1511-1514.
9. NARMS (National Antimicrobial Resistance Monitoring System). Escherichia coli - 2002 Report. Available at www.ars.usda.gov/ SP2UserFiles/Place/66120508/NARMS/ecoli_2002/TABLE1.pdf. Accessed 22 April 2007.
10. NARMS (National Antimicrobial Resistance Monitoring System). 2003 human isolates final report. Available at www.cdc.gov/narms/annual/2003/ NARMS2003AnnualReport.pdf. Accessed 22 April 2007.
11. CLSI (Clinical and Laboratory Standards Institute). Performance standards for antimicrobial disk and dilution susceptibility tests for bacterial isolated from animals; approved standard. 2002. NCCLS M31-A2.
12. National Organic Program. Organic production and handling standards, October 2002. Available at www.ams.usda.gov/nop/FactSheets/ProdHandE.html. Accessed 22 April 2007.
13. Organic Trade Association. The OTA 2004 Manufacturer Survey Overview. Available at www.ota.com/pics/documents/2004SurveyOverview.pdf. Accessed 22 April 2007.
14. Plumb DC. Plumb's Veterinary Drug Handbook, 5th edition. Ames, IA: Blackwell, 2005.
15. Sato K, Bartlett PC, Saeed MA. Antimicrobial susceptibility of Escherichia coli isolates from dairy farms using organic versus conventional production methods. J Am Vet Med Assoc 2005;226:589-594.
16. Schmidt H, von Maldeghem J, Frosch M, Karch H. Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996. J Antimicrob Chemother 1998;42:548-550.
17. Schroeder CM, Meng J, Zhao S, et al. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg Infect Dis 2002;8:1409-1414.
18. Shepherd R, Magnusson M, Sjoden PO. Determinants of consumer behavior related to organic foods. Ambio 2005;34:352-359.
19. Tarr PI. Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 1995;20:1-8; quiz, 9-10.
20. Tsuboi I, Ida H, Yoshikawa E, et al. Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996. Antimicrob Agents Chemother 1998;42:431-432.
21. Wetzstein HG. Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrob Agents Chemother 2005;49:4166-4173.
22. Zwald AG, Ruegg PL, Kaneene JB, et al. Management practices and reported antimicrobial usage on conventional and organic dairy farms. J Dairy Sci 2004;87:191-201.